粵桂股份(000833.SZ)及子公司2021年度擬向銀行申請總規模不超23.69億元授信額度
格隆匯 12 月 31日丨粵桂股份(000833.SZ)公佈,公司於2020年12月30日召開第八屆董事會第二十次會議,審議通過了《關於向銀行申請2021年度授信額度暨預計擔保額度的議案》。
根據2021年度經營發展的需要,為保證公司及子公司現金流量充足及滿足經營融資需求,公司及子公司擬向銀行申請總規模不超過23.69億元人民幣的授信額度。為保證此綜合授信融資方案的順利完成,公司及子公司對此次授信額度提供總額度不超過21.154億元的擔保額度。授信及擔保期限自股東大會審議通過之日起至下一年度審議該事項的股東大會通過前有效。以上授信及擔保額度不含董事會已授權未到期的長期固定資產授信4.5億元及擔保3.5億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.